Anti-synthetase Inflammatory Myositis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-08-25
Clinical Trial Results: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Phase 2 proof-of-concept study evaluating the efficacy and safety of Daxdilimab in dermatomyositis and anti-synthetase inflammatory myositis…